The role of ATM in response to metformin treatment and activation of AMPK

Nature Genetics

Volumn 44, Issue 4, 2012, Pages 359-360

  Yee, Sook Wah ^a   Chen, Ligong ^a   Giacomini, Kathleen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 6 (1 THIANTHRENYL) 4 PYRANONE; ADENYLATE KINASE; ATM PROTEIN; MESSENGER RNA; METFORMIN; ORGANIC CATION TRANSPORTER;

ANIMAL CELL; DOUBLE STRANDED DNA BREAK; DRUG MECHANISM; FIBROBLAST; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL CYCLE PROTEINS; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; HUMANS; METFORMIN; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84859293531     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2236     Document Type: Letter

References (11)

1. The GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group & The Wellcome Trust Case Control Consortium 2. Nat. Genet. 43, 117-120 (2011).
2. Sanli, T. et al. Int. J. Radiat. Oncol. Biol. Phys. 78, 221-229 (2010).
3. Sun, Y., Connors, K.E. & Yang, D.Q. Mol. Cell. Biochem. 306, 239-245 (2007).
4. Fu, X., Wan, S., Lyu, Y.L., Liu, L.F. & Qi, H. PLoS One 3, e2009 (2008).
5. Shu, Y. et al. J. Clin. Invest. 117, 1422-1431 (2007).
6. Ahlin, G. et al. Pharmacogenomics J. 11, 400-411 (2011).
7. Chen, L. et al. Pharmacogenet. Genomics 20, 687-699 (2010).
8. Minematsu, T. & Giacomini, K.M. Mol. Cancer Ther. 10, 531-539 (2011).
9. Canman, C.E. et al. Science 281, 1677-1679 (1998).
10. Zhou, G. et al. J. Clin. Invest. 108, 1167-1174 (2001).
11. Foretz, M. et al. J. Clin. Invest. 120, 2355-2369 (2010).